title: US health insurance is an obstacle to disease-modifying treatments in MS.
authors.affiliation: From the Department of Neurology (D.B.), Oregon Health & Science University; MS Center of Excellence-West (D.B.), VA Portland Health Care System, Portland OR; and Multiple Sclerosis Center (F.P.), University of Catania, Italy. bourdett@ohsu.edu.
authors.forename: Dennis
authors.initials: D
authors.lastname: Bourdette
authors.affiliation: From the Department of Neurology (D.B.), Oregon Health & Science University; MS Center of Excellence-West (D.B.), VA Portland Health Care System, Portland OR; and Multiple Sclerosis Center (F.P.), University of Catania, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Patti
mesh_terms: D006801:Humans; D056747:Immunomodulation; D007348:Insurance, Health / Q000191:economics / Q000706:statistics & numerical data*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy* / Q000191:economics; D014481:United States